Chimeric antigen with enhanced multi-immune function through specific binding to target cell, and use thereof
AssigneeRnagene Inc.
InventorWoo Ghil LEE
Life of this patent
Estimating the term…
Abstract
The present invention relates to a chimeric antigen, which binds specifically to target cells and enhances multiple immune functions, and the use thereof. Specifically, the present invention relates to: a chimeric antigen for inducing multiple immune functions wherein an immune response-inducing domain and a domain for inducing target cell-specific binding are fused to each other; a pharmaceutical composition for preventing or treating cancer, containing, as an active ingredient, the chimeric antigen for enhancing multiple immune functions; a pharmaceutical composition for preventing or treating infectious disease; a composition for enhancing immunity; and a vaccine composition.
Claims15
A chimeric antigen for enhancing multiple immune functions wherein an immune response-inducing domain and a domain for inducing target cell-specific binding are fused to each other.
Dependencies are inferred from the claim text.